ImmunoPrecise Antibodies Ltd. (HYFT) — Free Cash Flow Generation Index

Latest as of October 2020: -0.62x

ImmunoPrecise Antibodies Ltd. (HYFT) has a Free Cash Flow Generation Index of -0.62x as of October 2020. Free cash flow of $-274.98K represents -1% of operating cash flow ($440.23K). Read ImmunoPrecise Antibodies Ltd. balance sheet liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

-0.62x

Free Cash Flow / Operating CF

Free Cash Flow

$-274.98K

USD

Operating Cash Flow

$440.23K

USD

Capital Expenditures

$715.21K

USD

ImmunoPrecise Antibodies Ltd. Free Cash Flow Generation Index (2016–2016)

Historical FCF Generation Index trend for ImmunoPrecise Antibodies Ltd. across 1 annual periods. Explore HYFT capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for ImmunoPrecise Antibodies Ltd. (2016–2016)

Year-by-year Free Cash Flow Generation Index for ImmunoPrecise Antibodies Ltd.. For the full company profile including market capitalisation, see HYFT market cap.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2016	0.94x	$266.61K	$284.09K	$17.48K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).